# Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes

> **NCT01777555** · PHASE2 · COMPLETED · sponsor: **Acorda Therapeutics** · enrollment: 89 (actual)

## Conditions studied

- Idiopathic Parkinson's Disease

## Interventions

- **DRUG:** CVT-301
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01777555
- **Lead sponsor:** Acorda Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2018-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01777555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01777555, "Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01777555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*